-
R648692-100mgROCK inhibitor-2 is a selective dual ROCK1 and ROCK2 inhibitor with IC 50 s of 17 nM and 2 nM, respectivelyForm:SolidIC50& Target:ROCK1 17 nM (IC 50 ) ROCK2 2 nM (IC 50 )
-
R648692-10mgROCK inhibitor-2 is a selective dual ROCK1 and ROCK2 inhibitor with IC 50 s of 17 nM and 2 nM, respectivelyForm:SolidIC50& Target:ROCK1 17 nM (IC 50 ) ROCK2 2 nM (IC 50 )
-
R648692-25mgROCK inhibitor-2 is a selective dual ROCK1 and ROCK2 inhibitor with IC 50 s of 17 nM and 2 nM, respectivelyForm:SolidIC50& Target:ROCK1 17 nM (IC 50 ) ROCK2 2 nM (IC 50 )
-
R648692-50mgROCK inhibitor-2 is a selective dual ROCK1 and ROCK2 inhibitor with IC 50 s of 17 nM and 2 nM, respectivelyForm:SolidIC50& Target:ROCK1 17 nM (IC 50 ) ROCK2 2 nM (IC 50 )
-
R648692-5mgROCK inhibitor-2 is a selective dual ROCK1 and ROCK2 inhibitor with IC 50 s of 17 nM and 2 nM, respectivelyForm:SolidIC50& Target:ROCK1 17 nM (IC 50 ) ROCK2 2 nM (IC 50 )
-
R655527-1mlROCK inhibitor-2 is a selective dual ROCK1 and ROCK2 inhibitor with IC 50 s of 17 nM and 2 nM, respectivelyIC50& Target:ROCK1 17 nM (IC 50 ) ROCK2 2 nM (IC 50 )
-
R648191-10mgROCK-IN-1 is a potent inhibitor of ROCK , with an IC 50 of 1.2 nM for ROCK2 .In VitroROCK-IN-1 shows potent cellular efficacy, with an EC 50 of 200 nM. MCE has not independently confirmed the accuracy of these methods. They are for reference
-
R648191-25mgROCK-IN-1 is a potent inhibitor of ROCK , with an IC 50 of 1.2 nM for ROCK2 .In VitroROCK-IN-1 shows potent cellular efficacy, with an EC 50 of 200 nM. MCE has not independently confirmed the accuracy of these methods. They are for reference
-
R648191-5mgROCK-IN-1 is a potent inhibitor of ROCK , with an IC 50 of 1.2 nM for ROCK2 .In VitroROCK-IN-1 shows potent cellular efficacy, with an EC 50 of 200 nM. MCE has not independently confirmed the accuracy of these methods. They are for reference
-
R647233-10mgROCK2-IN-2 is a selective ROCK2 inhibitor extracted from patent US20180093978A1, Compound A-30, has an IC 50 of <1 μM.In VitroRho-associated protein kinase (ROCK) is a member of the serine-threonine protein kinase family. ROCK, which exists in
-
R647233-1mgROCK2-IN-2 is a selective ROCK2 inhibitor extracted from patent US20180093978A1, Compound A-30, has an IC 50 of <1 μM.In VitroRho-associated protein kinase (ROCK) is a member of the serine-threonine protein kinase family. ROCK, which exists in
-
R647233-25mgROCK2-IN-2 is a selective ROCK2 inhibitor extracted from patent US20180093978A1, Compound A-30, has an IC 50 of <1 μM.In VitroRho-associated protein kinase (ROCK) is a member of the serine-threonine protein kinase family. ROCK, which exists in